Search research articles
Contact Us
Filters
Showing results (101-110 of 122) with videos related to
Page
of 13
Sort By:
Journal of Cancer Research and Clinical Oncology
|
April 24, 2017
Early whole brain radiotherapy in primary CNS lymphoma: negative impact on quality of life in the randomized G-PCNSL-SG1 trial
Ulrich Herrlinger, Niklas Schäfer, Rolf Fimmers, et al.
Wiener Klinische Wochenschrift
|
June 24, 2006
3-D Conformal radiotherapy of localized prostate cancer within an Austrian-German multicenter trial: a prospective study of patients' acceptance of the rectal balloon during treatment
Gregor Goldner, Hans Geinitz, Stefan Wachter, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 8, 2005
3-D conformal radiotherapy of localized prostate cancer: a subgroup analysis of rectoscopic findings prior to radiotherapy and acute/late rectal side effects
Gregor Goldner, Frank Zimmermann, Horst Feldmann, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
February 26, 2009
Moderate risk-adapted dose escalation with three-dimensional conformal radiotherapy of localized prostate cancer from 70 to 74 Gy. First report on 5-year morbidity and biochemical control from a prospective Austrian-German multicenter phase II trial
Gregor Goldner, Valentin Bombosch, Hans Geinitz, et al.
Annals of Neurology
|
September 27, 2002
Gliomatosis cerebri: molecular pathology and clinical course
Ulrich Herrlinger, Jörg Felsberg, Wilhelm Küker, et al.
BMC Cancer
|
July 29, 2005
Intensity modulated radiotherapy for high risk prostate cancer based on sentinel node SPECT imaging for target volume definition
Ute Ganswindt, Frank Paulsen, Stefan Corvin, et al.
Onkologie
|
February 5, 2005
Meeting report: primary central nervous system lymphoma: standards of care and future perspectives
Ulrich Herrlinger, Agnieszka Korfel, Holger Hebart, et al.
Cancer Research
|
February 7, 2002
Antineoplastic effects of chemotherapeutic agents are potentiated by NM-3, an inhibitor of angiogenesis
Corinne L Reimer, Naoki Agata, Jennifer G Tammam, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 26, 2006
Proctitis after external-beam radiotherapy for prostate cancer classified by Vienna Rectoscopy Score and correlated with EORTC/RTOG score for late rectal toxicity: results of a prospective multicenter study of 166 patients
Gregor Goldner, Birgit Tomicek, Gerd Becker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 19, 2005
Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial
Volker Budach, Martin Stuschke, Wilfried Budach, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 122) with videos related to
Sort By:
Page
of 13
Journal of Cancer Research and Clinical Oncology
|
April 24, 2017
Early whole brain radiotherapy in primary CNS lymphoma: negative impact on quality of life in the randomized G-PCNSL-SG1 trial
Ulrich Herrlinger, Niklas Schäfer, Rolf Fimmers, et al.
Wiener Klinische Wochenschrift
|
June 24, 2006
3-D Conformal radiotherapy of localized prostate cancer within an Austrian-German multicenter trial: a prospective study of patients' acceptance of the rectal balloon during treatment
Gregor Goldner, Hans Geinitz, Stefan Wachter, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 8, 2005
3-D conformal radiotherapy of localized prostate cancer: a subgroup analysis of rectoscopic findings prior to radiotherapy and acute/late rectal side effects
Gregor Goldner, Frank Zimmermann, Horst Feldmann, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
February 26, 2009
Moderate risk-adapted dose escalation with three-dimensional conformal radiotherapy of localized prostate cancer from 70 to 74 Gy. First report on 5-year morbidity and biochemical control from a prospective Austrian-German multicenter phase II trial
Gregor Goldner, Valentin Bombosch, Hans Geinitz, et al.
Annals of Neurology
|
September 27, 2002
Gliomatosis cerebri: molecular pathology and clinical course
Ulrich Herrlinger, Jörg Felsberg, Wilhelm Küker, et al.
BMC Cancer
|
July 29, 2005
Intensity modulated radiotherapy for high risk prostate cancer based on sentinel node SPECT imaging for target volume definition
Ute Ganswindt, Frank Paulsen, Stefan Corvin, et al.
Onkologie
|
February 5, 2005
Meeting report: primary central nervous system lymphoma: standards of care and future perspectives
Ulrich Herrlinger, Agnieszka Korfel, Holger Hebart, et al.
Cancer Research
|
February 7, 2002
Antineoplastic effects of chemotherapeutic agents are potentiated by NM-3, an inhibitor of angiogenesis
Corinne L Reimer, Naoki Agata, Jennifer G Tammam, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 26, 2006
Proctitis after external-beam radiotherapy for prostate cancer classified by Vienna Rectoscopy Score and correlated with EORTC/RTOG score for late rectal toxicity: results of a prospective multicenter study of 166 patients
Gregor Goldner, Birgit Tomicek, Gerd Becker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 19, 2005
Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial
Volker Budach, Martin Stuschke, Wilfried Budach, et al.
Page
of 13